Trulieve Cannabis Corp.

Trulieve Cannabis Corp.

TRLV
Trulieve Cannabis Corp.US flagNew York Stock Exchange
10.72
USD
-0.15
- -
1.82BMarket Cap
Trulieve Cannabis Corp.
TRLV
(New York Stock Exchange)

Recent

price

10.72

P/E

ratio

- -

div

yld

- -

ROIC.AI

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
- -
- -
1.01
2.29
4.59
6.69
6.48
5.98
6.24
6.17
5.93
Revenue per Share
-0.04
0.01
- -
- -
0.11
0.48
0.55
0.13
-1.31
-2.79
-0.82
-0.61
-2.46
Basic EPS, GAAP
-0.02
-0.02
- -
- -
-0.19
-0.5
-0.37
-2.04
-0.88
0.8
0.65
1.11
1.15
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
0.95
1.2
3.75
11.89
10.38
7.6
6.6
6.04
3.99
Book Value per Share
- -
- -
- -
- -
0.86
0.9
2.41
1.45
0.83
0.07
-0.43
-0.63
0.73
Tangible Book Value per Share
4
4
110
110
102
110
114
139
188
189
190
191
192
Basic Weighted Avg Shares
- -
- -
- -
- -
103
253
522
932
1,218
1,129
1,186
1,181
1,139
Sales/Revenue/Turnover
-16,912.65
-23,717.76
- -
- -
34.13
44.83
41.87
22.47
10.32
8.2
7.8
12.56
11.51
Operating Margin (%)
- -
- -
- -
- -
3
16
30
78
186
171
166
173
170
Depreciation Expense
- -
- -
- -
- -
11
53
63
18
-246
-527
-155
-116
-473
Net Income, GAAP
- -
- -
- -
- -
67.03
48.79
59.99
82.68
- -
- -
462.59
227.51
1,896
Effective Tax Rate (%)
-14,768.75
10,162.02
- -
- -
10.59
21
12.08
1.93
-20.2
-46.65
-13.07
-9.85
-41.55
Profit Margin (%)
- -
- -
- -
- -
46
113
185
355
383
362
466
436
470
Working Capital
- -
- -
- -
- -
13
77
266
832
943
770
797
533
551
LT Debt
- -
- -
- -
- -
104
133
448
2,147
1,928
1,409
1,249
1,143
766
Total Equity
- -
- -
- -
- -
16.52
31.72
18.07
1.92
- -
- -
-15.64
-9.97
-39.64
Return on Invested Capital (%)
- -
-10.71
- -
- -
18.54
33.7
14.92
1.26
- -
- -
-17.55
-10.13
-50.81
Return on Capital (%)
- -
- -
- -
- -
- -
44.79
21.69
1.39
-12.07
-31.49
-11.59
-9.61
-47.51
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
30
31
26
LT Borrowings
228
286
285
LT Finance Leases
306
312
266
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
192
192
192
Market Capitalization
1,671
1,077
1,891

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
563
653
565
Cash, Cash Equivalents & STI
256
353
325
Accounts Receivable, Net
10
14
4
Inventories
242
242
187
Total Current Liabilities
127
124
95
Payables & Accruals
61
79
61
ST Debt
30
31
26
Deferred Revenue
10
10
7

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-3,675.45%
64.49%
-8.49%
Free Cash Flow
9,280.9%
78.46%
71.47%
Net Income, GAAP
-3,090.75%
-303.48%
-24.97%
Sales/Revenue/Turnover
- -
21.34%
-0.45%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
298
303
284
301
1,186
2025
298
302
288
293
1,181
2026
287
271
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.12
-0.06
-0.32
-0.31
-0.82
2025
-0.17
-0.07
-0.14
-0.22
-0.61
2026
0.01
-2.11
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Trulieve Cannabis Corp. engages in vertically integrated cannabis operations across the United States, focusing on cultivation, processing, distribution, and retail sales of medical and adult-use cannabis products. The company manufactures and distributes a wide range of cannabis花 products, including flower, concentrates, edibles, tinctures, topicals, and related ancillary products through company-owned dispensaries and, in some states, delivery channels, under multiple brand lines. Main products and services: - Cultivation and production: indoor and greenhouse cultivation; extraction and manufacturing of cannabis concentrates and oil-based products; cryo-freeze and other advanced processing methods; development of pre-rolls and finished consumer goods. - Retail and distribution: branded dispensaries offering direct-to-consumer sales of cannabis and derivative products; in-state medical and adult-use retail operations; managed delivery services where permitted; wholesale supply of products to partner retailers in select markets. - Product categories and brands: cannabis flower; concentrates (cannabis oils, distillates, and extracts); edibles (gummies, chocolates, baked goods); topicals (creams and balms); beverages and other derivative formats; consumer packaging and accessories; proprietary and partner brands such as Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, Trekkers, and Roll One. - Ancillary services: quality control laboratories, post-harvest processing, packaging and labeling compliance, product development and R&D for new formats and dosage forms, and compliance support for regulated markets. Latest major company changes: - Strategic expansion in key markets through acquisitions and integrations of dispensaries or cultivation facilities to broaden geographic footprint and increase retail density; these moves include consolidations and divestitures of ancillary facilities as part of portfolio optimization. - Regulatory and market expansion efforts, including pursuing state-by-state growth with enhanced vertical integration capabilities, enabling more control over supply chains and product quality. - Product and branding updates across platforms, including new product launches and expansions of existing brand lines to address evolving consumer preferences and regulatory changes. - Corporate restructurings and leadership announcements aligned with growth strategies and capital efficiency goals, including realignment of operating segments to reflect state-level operations rather than traditional multi-segment reporting. Industry context and target markets: - Industry: cannabis, with operations spanning cultivation, processing, distribution, and retail within regulated U.S. markets. - Segments: medical cannabis, adult-use recreational cannabis, and derivative product trends such as concentrates, edibles, and topicals. - Customer base: registered medical cannabis patients and adult-use consumers in states where the company operates, with a growing emphasis on brand-based consumer shopping experiences at company-owned locations and compliance-backed delivery where available. - Geographic footprint: United States, with a focus on states permitting medical and/or adult-use cannabis sales; headquarters and primary operational hubs located in states with established cultivation and retail infrastructure. Founding and corporate structure: - Founding year: established prior to the 2010s as a pioneer in vertically integrated cannabis operations in the U.S. - Headquarters: United States (headquarters locations in states where the company maintains primary corporate functions and strategic leadership). - Subsidiaries/affiliates: operates through a network of owned and operated dispensaries, cultivation facilities, processing labs, and distribution centers; maintains relationships with state regulators and license holders to support regulated commerce. Note: Trulieve emphasizes a vertically integrated, asset-light approach where feasible within state-by-state regulatory constraints, leveraging in-house cultivation, processing, and retail networks to optimize product quality, supply chain efficiency, and direct-to-consumer accessibility. The company maintains a broad portfolio of products and brands designed to address diverse consumer preferences and medical needs while pursuing ongoing expansion and regulatory advancement across the U.S. market.

Company News

  • Trulieve Cannabis (NYSE:TRLV) Shares Gap Down – Should You Sell?

  • MSOS: Pause On Cannabis Rescheduling - And Why Trulieve Is A Sneaky Pick

  • 3 Cannabis Stocks to Watch Heading Out of September

  • Trulieve Announces Exclusive Master Licensing Agreement with Connected for Florida and Texas

  • Trulieve Cannabis Corp. (NYSE:TRLV) Short Interest Update

  • Cannabis Stocks Enter A New Era For Investors nd Enthusiasts

  • Trulieve Cannabis Corp (TRLV) Shares Surge 8.4% -- What GF Score of 55 Tells Investors

  • Trulieve Cannabis Corp. Added to S&P Total Market and S&P Completion Indices

  • Trulieve: As Regulatory Headwinds Wane, Value Creation Is On The Cards

  • Trulieve to Open Medical Cannabis Dispensary in Dunwoody, Georgia

  • Trulieve Announces September 2026 Event Participation

  • 3 Marijuana Stocks To Focus On For Future Growth And Profits

  • Trulieve to Ring The Closing Bell at the New York Stock Exchange as First U.S. Cannabis Company Listed on the NYSE

  • 3 Marijuana Stocks For Investors To Consider

  • Trulieve Completes Redomicile from British Columbia to Delaware

  • Trulieve Cannabis: First NYSE-Listed Cannabis Stock Is A Buy

  • Trulieve Cannabis Q2 Earnings Call Highlights

  • Trulieve Cannabis Corp. (TRLV) Q2 2026 Earnings Call Transcript

  • Trulieve Reports Second Quarter 2026 Results

  • Trulieve Reports Second Quarter 2026 Results